Prosecution Insights
Prosecution Insights
24 pending office actions • 12 art units • 21 examiners • 0 of 24 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (12%) |
| §103 only | 6 (25%) |
| §102 only | 2 (8%) |
| §112 only | 3 (12%) |
| Double-patenting only | 2 (8%) |
| Double-patenting + other | 2 (8%) |
| Multi-statute (no §101) | 6 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DUFFY, PATRICIA ANN | 3 | 52.7% | +34.2% |
| LI, BAO Q | 2 | 75.5% | +26.4% |
| CHHAY, BONIRATH | 1 | 75.0% | +0.0% |
| GRASER, JENNIFER E | 1 | 76.5% | +23.6% |
| BOESEN, AGNIESZKA | 1 | 68.3% | +22.0% |
| KIM, YUNSOO | 1 | 65.8% | +34.8% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| PAK, YONG D | 1 | 74.6% | +14.3% |
| RICCI, CRAIG D | 1 | 53.5% | +52.6% |
| RONEY, CELESTE A | 1 | 62.8% | +17.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18683531 | LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME | RONEY, CELESTE A | 43d overdue |
| 18285088 | PROCESS FOR BIOCONJUGATE PRODUCTION | GOUGH, TIFFANY MAUREEN | 40d |
| 18667046 | RSV IMMUNIZATION REGIMEN | BOESEN, AGNIESZKA | — |
| 18687892 | IVT RNA MANUFACTURING PROCESS | BRETZ, COREY LANE | — |
| 18686089 | Shigella Vaccine | DUFFY, PATRICIA ANN | — |
| 18684923 | T7 RNA POLYMERASE VARIANTS FOR RNA SYNTHESIS | PAK, YONG D | — |
| 18268736 | RNA VACCINE AGAINST SARS-COV-2 VARIANTS | LI, BAO Q | — |
| 18256749 | Hyper-Blebbing Bacteria | DUFFY, PATRICIA ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18683531 | LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME | RONEY, CELESTE A | 43d overdue |
| 17618283 | MUCOSAL VACCINE FORMULATIONS | LI, BAO Q | 16d overdue |
| 18721985 | Method for Preparing Outer Membrane Vesicles | GRASER, JENNIFER E | — |
| 18718636 | VACCINE | DUFFY, PATRICIA ANN | — |
| 18667046 | RSV IMMUNIZATION REGIMEN | BOESEN, AGNIESZKA | — |
| 18620109 | MULTIPLE FUNCTIONALIZED noMV CONJUGATES | KIM, YUNSOO | — |
| 18686089 | Shigella Vaccine | DUFFY, PATRICIA ANN | — |
| 18684923 | T7 RNA POLYMERASE VARIANTS FOR RNA SYNTHESIS | PAK, YONG D | — |
| Art Unit | Apps |
|---|---|
| 1645 | 8 |
| 1671 | 3 |
| 1641 | 1 |
| 1652 | 1 |
| 1611 | 1 |
| 1612 | 1 |
| 1631 | 1 |
| 1699 | 1 |
| 1619 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18844433 | IMMUNOGENIC COMPOSITIONS | CHHAY, BONIRATH | — | DP | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18721985 | Method for Preparing Outer Membrane Vesicles | GRASER, JENNIFER E | 1645 | §103 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18718636 | VACCINE | DUFFY, PATRICIA ANN | 1645 | §102 | Non-Final OA | — | Pending | Jun 11, 2024 |
| 18667046 | RSV IMMUNIZATION REGIMEN | BOESEN, AGNIESZKA | — | §101DP | Non-Final OA | — | Pending | May 17, 2024 |
| 18620109 | MULTIPLE FUNCTIONALIZED noMV CONJUGATES | KIM, YUNSOO | 1641 | §102§103§112DPOther | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18687892 | IVT RNA MANUFACTURING PROCESS | BRETZ, COREY LANE | — | §102§103§112 | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18686089 | Shigella Vaccine | DUFFY, PATRICIA ANN | 1645 | §103§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18684923 | T7 RNA POLYMERASE VARIANTS FOR RNA SYNTHESIS | PAK, YONG D | 1652 | §101§102§103§112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18683535 | FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF | RICCI, CRAIG D | 1611 | §103 | Non-Final OA | — | Pending | Feb 14, 2024 |
| 18683531 | LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME | RONEY, CELESTE A | 1612 | §103§112 | Non-Final OA | 43d overdue | Pending | Feb 14, 2024 |
| 18438870 | MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES | ZEMAN, ROBERT A | 1645 | §103 | Non-Final OA | — | Pending | Feb 12, 2024 |
| 18508435 | LIPID FORMULATIONS WITH RNA ENCODING IMMUNOGENS | LEONARD, ARTHUR S | 1631 | §103DP | Non-Final OA | — | Pending | Nov 14, 2023 |
| 18463099 | IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF | BLUMEL, BENJAMIN P | 1671 | DP | Final Rejection | — | Pending | Sep 07, 2023 |
| 18268736 | RNA VACCINE AGAINST SARS-COV-2 VARIANTS | LI, BAO Q | 1671 | §103§112 | Non-Final OA | — | Pending | Jun 21, 2023 |
| 18256749 | Hyper-Blebbing Bacteria | DUFFY, PATRICIA ANN | 1645 | §101§102§112 | Non-Final OA | — | Pending | Jun 09, 2023 |
| 18039514 | MODIFICATION OF SAPONINS | KANE, TREVOR LOGAN | 1699 | §112 | Non-Final OA | — | Pending | May 31, 2023 |
| 18011643 | ADJUVANTS | GOTFREDSON, GAREN | 1619 | §103 | Final Rejection | — | Pending | Dec 20, 2022 |
| 18008771 | DOCK TAG SYSTEM | COFFA, SERGIO | 1658 | §103Other | Non-Final OA | 28d | Pending | Dec 07, 2022 |
| 17923252 | MICROFLUIDIC MIXING DEVICE AND METHODS OF USE | NGUYEN, HENRY H | 1758 | §103§112 | Final Rejection | — | Pending | Nov 04, 2022 |
| 17763354 | IMMUNOGENIC COMPOSITIONS | MORGAN, BAILEY MICHELLE | 1645 | §103 | Non-Final OA | — | Pending | Mar 24, 2022 |
| 17632270 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | CHEONG, CHEOM-GIL | 1645 | §112 | Non-Final OA | 51d overdue | Pending | Feb 02, 2022 |
| 17618283 | MUCOSAL VACCINE FORMULATIONS | LI, BAO Q | 1671 | §102 | Final Rejection | 16d overdue | Pending | Dec 10, 2021 |
| 18425500 | BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, METHODS OF PRODUCTION THEREOF, AND METHODS OF USE THEREOF | GANGLE, BRIAN J | 1645 | §112 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18285088 | PROCESS FOR BIOCONJUGATE PRODUCTION | GOUGH, TIFFANY MAUREEN | 1651 | §103§112 | Non-Final OA | 40d | Pending | Sep 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial